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Abstract
Introduction: propolis is a substance that has aroused the interest 
of many researchers because of its numerous therapeutic properties, 
antibacterial and antifungal.
Objectives: identifying the species of Candida and evaluate the an-
tifungal effect of red propolis yeast oral cavity.
Method: this is a clinical in vitro study with saliva samples co-
llected from 152 patients treated at the dental office of the Family 
Health Strategy in the city of São Bento-pB. the identification of 
Candida species was made through the Chrom Ágar Candida. the 
antifungal activity of the propolis extract was analyzed in four di-
fferent concentrations: 100%, 75%, 50% and 25%, through the 
agar diffusion test.
Results: the most prevalent species was C. albicans; antifungal ac-
tion as to the concentration of 25% of the propolis extract was that 
apparently demonstrated greater efficacy, compared to the highest 
concentration.
Conclusion: the inhibitory effect of propolis against Candida may 
have been influenced by the concentration of alcohol present in the 
extract. to test this hypothesis suggests that search is performed with 
extracts of propolis and at the same time with the alcohol, in both 
concentrations and different environmental conditions. this study 
offers subsidies for other professionals employ different methodolo-
gies and propolis concentrations with other substances in order to test 
the antimicrobial action of these.
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Introduction
Oral Candidiasis is an infection caused by Candida 
yeasts, saprobes microorganisms that, dependent 
on predisposing factors, become pathogenic [1]. 
this type of infection is most common in immuno-
compromised individuals and presented increasing 
incidence in recent years [2]. C. albicans is the most 
frequently identified species and therefore respon-
sible for this type of infection. However, infections 
caused by other species of the genus are becoming 
more frequent, being cited approximately 150 spe-
cies, most isolated from the oral cavity [3].
C. albicans is considered the main opportunistic 
pathogenic yeast to be the most frequently isolated 
species in humans. However, in recent decades the-
re has been a significant increase of other species. 
the main of medical concern are C. parapsilosis, C. 
tropicalis, C. krusei, C. guilliermondii, C. glabrata, C. 
lusitaniae. C. kefyr, C. famata, C. dubliniensis [4-5].
the species identification is important, fungal in-
fections caused by Candida, since the pathogenicity 
and sensitivity to a particular antifungal vary bet-
ween different species [6]. 
the widespread use of azole antifungal for the 
treatment of oral candidiasis appears to be a ma-
jor factor in the increased frequency of Candida 
non-albicans species, especially those naturally 
more resistant to this class of antifungals such 
as C. glabrata and C. krusei [7]. Recent studies 
indicate that there is an increase in resistance of 
Candida species to antifungal drugs available on 
the market [8].
A drawback of the azole is that they are depen-
ding on the concentration, fungistatic, not fungici-
dal, which may contribute to the development of 
resistance in clinical isolates [9]. Resistance to azole 
antifungals may result from target sites of mutation 
or increased gene expression of proteins responsible 
for the transport of antifungal to the outside, or 
even the combination of these two mechanisms, 
which have been observed in isolated C. albicans 
[10]. 
this fact has stimulated the search for increasin-
gly new antifungal agents from natural sources and 
propolis emerges as an important coupled to pre-
sent a wide diversity of active compounds, many 
still unknown, with reported biological properties, 
which may enable the discovery of new bioactive 
molecules to processes treatments oral disease.
the range of biological activities of propolis is 
higher in tropical areas of the world, reflecting the 
plant diversity of these regions [11]. Because of the 
diversity of the flora, propolises from Brazil were 
grouped into 12 different groups, according to the 
chemical composition and biological activities. Cu-
rrently, a new variety of propolis, originating from 
the mangrove area in the state of Alagoas (Bra-
zil), had its botanical origin identified as Dalbergia 
ecastophyllum, a kind of legume [12]. this propolis, 
called "red propolis", because of its intense red co-
loration, was scored as the 13th type of brazilian 
propolis and have shown various biological activities 
in vitro assays [13]. 
trying to understand the action of propolis, this 
research was carried out aiming to identify Candida 
species in the oral cavity and evaluate in vitro anti-
fungal activity of the red propolis extract the yeast 
of the oral cavity.
Material and Method
the research is a clinical study in vitro with sali-
va samples collected from 152 patients treated at 
the dental office of the Family Health Strategy ivan 
Olimpo Segundo, in the municipality of São Bentin-
ho-pB, with Oral Swab Sterile aid. the handling of 
clinical samples was performed at the Laboratory 
of Vocational technology Center (VtC) of the Fe-
deral University of Campina Grande, pB, Campus 
pombal-pB. patients consented to participate in the 
survey after they had read, understood and signed 
two copies of a Free and Clear informed Consent. 
in compliance with Resolution 466/12, the research 
was approved by the Research Ethics Committee of 
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the Federal University of Campina Grande, CAAE 
37184414.5.0000.5575 protocol. Made the collec-
tion of oral secretions, identification of the fungus 
in culture was carried out from the sow Agar potato 
Dextrose. the plates were incubated at 37ºC for five 
days. After this period, the growth characteristics of 
Candida colonies were checked. the identification 
(Figure 1) occurred by studying the macroscopic 
aspects, micro morphological and biochemical in 
Chrom Ágar Candida®. the medium used indicates 
green colonies, for C. albicans; rugose rose, for C. 
krusei; metallic blue, for C. tropicalis; and white to 
violet, for other species [10, 14-15].
the red propolis samples of Apis mellifera bees 
arising from the Dalbergia ecastophyllum (Bugiu-of-
tail), whose extract was held to 30% ethyl alcohol 
pA were acquired in Apiary EDiMEL- João pessoa 
- paraiba. 
the antifungal activity of the propolis extract was 
analyzed in four different concentrations: 100%, 
75%, 50% and 25%, determined by Agar diffu-
sion test in which the samples of Candida were 
identified and seeded Agar potato Dextrose and 
incubated at 35°C/48h. 
then, paper disks were soaked with 10μL used 
extract concentrations in the three and deposited 
on the surface of the agar. the plates were incu-
bated at 37°C/48h. After the measurement was 
performed halos of inhibition of Candida growth 
(Figure 2). From the results, it was considered ac-
tive product against the species of the microor-
ganisms under study which produced halos that 
above 10 mm in diameter [16].
Results
Saliva collection
the result of the salivary culture of 152 participants 
showed that 27.0% (n = 41) were positive for some 
species of Candida. the data in Table 1 demonstra-
te the Candida species identified in samples who-
se culture was positive. those findings, the species 
Candida albicans prevailed with 68.3% (n = 28), 
followed of other unidentified species from the cul-
ture medium with 14.6% (n = 6).
it was noticed by the findings that half (n = 14) 
species of C. albicans was samples from individuals 
with clinically healthy mouth, whose reason has 
been demand service restoration (n = 12) and the 
dental review (n = 2) (data not shown in tables).
the distribution of Candida species according to 
the gender of the participants, it is clear that in all 
Figure 1:  Candida species identification in samples 
of saliva, through the Chrom Agar Can-
dida®.
Source: Survey data. São Bentinho-PB, 2014
Figure 2:  Statement of antifungal action of the ex-
tract of red propolis at different concen-
trations – halo of inhibition in 20mm
Source: Survey data. São Bentinho, PB, 2014.
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species was greater prevalence in women; the ex-
ception of C. krusei because the percentages were 
the same for men and women (Table 2).
in addition to the evidence found on the higher 
prevalence of Candida in women, it was noticed the 
same fact in participants whose ages ranged from 
7 to 30 years, except for C. krusei, for all cases met 
the participants of full age (Table 3). 
interestingly, in this study, cases of Candida pre-
vailed in younger patients (Table 3) and only 9.7% 
(4/41) of cases of Candida wore partial denture, of 
which 2 were of C. albicans and 2 species, C. krusei 
(data not shown in tables).
Antifungal action of the red propolis 
extract
When testing the antifungal effect of propolis on 
41 samples with Candida species identified, it was 
noted that in 61% (n = 25) the result was positive. 
Analyzing this positivity, it was realized that, except 
for "other species identified" positive antifungal ac-
tion prevailed in the other, since the percentages 
were 64.3% (n = 18) in C. albicans, 75% (n = 3) in 
C. krusei, 66.7% (n = 2) in C. tropicalis (Table 4).
in the above mentioned concentrations of the 
propolis extract, added to samples containing Can-
dida species, it was possible to identify variations 
from 0 to 60 mm in the inhibition halos. Table 5 
reveals that the average of these halos increased as 
the concentrations were reduced; 0 mm the per-
centage reduced, as has reduced the concentration 
of extract; the positive 60mm was only observed at 
concentrations of 75% and 25%.
For greater understanding of antifungal action 
of red propolis extract were excluded lower results 
than or equal to 10 mm, at all concentrations, as 
shown in Chart 1. 
the Chart 1 indicate that by reducing red propo-
lis extract concentrations were added the cases of 
positivity antifungal action, from n = 13, concentra-
tion 100%, for n = 20, 25% in concentration. this 
association was not observed in the mean positive 
Table 1.  Species of Candida identified in samples of 
salivary culture (n = 41).
Species of Candida n %
C. albicans 28 68.3
C. krusei 4 9.8
C. tropicalis 3 7.3
Other species 6 14.6
Source: Survey data. São Bentinho-pB, 2014.
Table 4.  Distribution of Candida species identified in 
salivary culture as antifungal action of red 




C. albicans (n = 28) 18 64.3
C. krusei (n = 4) 3 75.0
C. tropicalis (n = 3) 2 66.7
Other species (n = 6) 2 33.3
Source: Survey data. São Bentinho-pB, 2014.
Table 2.  Distribution of Candida species identified 
in salivary culture according to the gender 




n % n %
C. albicans (n = 28) 23 82.1 5 17.9
C. krusei (n = 4) 2 50.0 2 50.0
C. tropicalis (n = 3) 3 100.0 0 0.0
Other species (n = 6) 5 83.3 1 16.7
Source: Survey data. São Bentinho-pB, 2014.
Table 3.  Distribution of Candida species identified 
in salivary culture according to the age of 
the respondents (n = 41).
Species of Candida
Age (years)
7 to 30 31 to 70
n % n %
C. albicans (n = 28) 20 71.4 8 28.6
C. krusei (n = 4) 0 0.0 4 100.0
C. tropicalis (n = 3) 3 100.0 0 0.0
Other species (n = 6) 5 83.3 1 16.7
Source: Survey data. São Bentinho-pB, 2014
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aspects of mergers, because there was almost equi-
valent concentrations at 100% and 50%; and at 
concentrations of 75% and 25%.
However, the graphical representation, this trend 
was not observed in millimetric terms, since there 
was an increasing linearity in the positivity of anti-
fungal action, as reduced or increased the concen-
tration of propolis extract. 
What was observed, on time, it was the highest 
percentage of 50 mm of positivity found in 23.5% 
(n = 4) for the concentration of the extract by 50%; 
and comparing all concentrations, the highest per-
centage of positivity was 20 mm, equal to 50% (n 
= 10), referring to the concentration of 25% of the 
extract.
Discussions
the high prevalence of C. albicans, found in this 
study corroborates the claim that this is the main 
agent of candidiasis, and this species is 60% of iso-
lates from clinical samples as it is part of human 
macrobiota [5]. 
in this sense, scholars [17] found in 82.8% of pa-
tients studied in C. albicans species. Meanwhile, in 
another study [18] obtained 62.66% and 66,4%, 
respectively, of the same species. 
About this prevalence, this fact can be justified 
due to the ability of the C. albicans has to produce 
secreting enzymes such as phospholipase, which 
plays an important role in the pathogenesis of these 
yeast [19-21]. the activity of extracellular phospholi-
pase facilitate the capacity of these yeasts to invade 
host cells and/or processed to remove antigens from 
the surface of these cells [22].
Contrary to this research, researchers [23] found 
in the saliva of all samples studied, a frequency 
of 48% (24/50) of C. albicans. that was the most 
prevalent species in all groups investigated, healthy 
Table 5.  Results of the halos of inhibition of antifungal action of the red propolis extract in the concen-
trations to 100%, 75%, 50% and 25%. (n=25).
Results (mm)
Concentrations of the red propolis extract
100% 75% 50% 25%
Average (SD) 18.80±17.64 22.00±18.26 24.00±17.32 26.40±18.00
Minimum-Maximum 0-50 0-60 0-50 0-60
0 mm 32% (n=8) 24% (n=6) 20% (n=5) 12% (n=3)
10 mm 16% (n=4) 12% (n=3) 12% (n=3) 8% (n=2)
20 mm 16% (n=4) 28% (n=7) 20% (n=5) 40% (n=10)
30 mm 16% (n=4) 12% (n=3) 20% (n=5) 16% (n=4)
40 mm 8% (n=2) 8% (n=2) 12% (n=3) 4% (n=1)
50 mm 12% (n=3) 12% (n=3) 16% (n=4) 8% (n=2)
60 mm - 4% (n=1) - 12% (n=3)
Source: Survey data. São Bentinho-pB, 2014.
Chart  1:  Distribution of antifungal action in mm of 
red propolis extract at concentrations to 
100%, 75%, 50% and 25%.
Source: Survey data. São Bentinho-PB, 2014.




Vol. 8 No. 136
doi: 10.3823/1735
This article is available at: www.intarchmed.com and www.medbrary.com 6
or not. However, they identified 47.7% of the C. 
albicans species in patients without oral problems.
Regarding gender, research [24] has shown that, 
in the sample of 51 women evaluated, 13 (25.5%) 
had a clinical diagnosis of Vulvovaginal Candidiasis 
(VVC), and of these, five (9.8%) showed yeasts of 
the genus Candida were also in the oral cavity. the 
authors observed that from the 15 women without 
clinical of VVC, 11 (73.3%) showed the yeast in the 
oral cavity, four (26.7%) in the vaginal mucosa and 
three (20%) in both sites. in addition, they assessed 
that although there was no statistically significant 
correlation between species and sites; women had 
oral and vaginal candidiasis due to different etiolo-
gic agents. therefore, they should always be advi-
sed to maintain good hygiene habits.
the frequency of Candida sp. in oral mucosal 
lesions was identified variable way, by researchers 
who investigated 832 biopsies of the oral mucosa, 
of which 27.2% were positive; they confirmed the 
increased presence of Candida in the lesions, being 
more frequent in males [25]. 
With regard to age, the C. albicans was found 
in the oral cavity from 3% to 48% of all adults 
and 45% to 65% of healthy individuals [26]; con-
tradicting the findings in research whose sample 
consisted of 98.4% adult participants, of which 
16.9% reported some pathological episode of oral 
candidiasis [27]. 
the relation age and C. albicans is reported in a 
study whose incidence of yeast increased with age, 
and its presence in the oral cavity, has reached 60% 
of the edentulous patients over 60 years, who had 
no signs of injury in the oral mucosa [28].
in recent decades there has been an increasing 
use of the propolis extracts to assist in the treatment 
of oral infections, due to their antimicrobial proper-
ties. 
Different methods in vitro are used for analysis 
of propolis extracts against species of Candida [29]. 
the antifungal activity of propolis in different spe-
cies of Candida was demonstrated in researches 
[30], and were also described the effects of the 
time of year in the activity of Brazilian propolis in 
C. albicans and C. tropicalis [31].
the results of this study did not reveal clarity re-
garding the antifungal effect of red propolis, since 
the trend of positivity of this action was not growing 
by increasing or decreasing the concentration of 
propolis extract. What was observed was that con-
centration at which 50% was obtained larger inhi-
bition zone, with an average of 33.5 mm (±11.7), 
then the concentration to 25%, average 32.0 mm 
(±15.4). On the other hand, analyzing the avera-
ge and standard deviation of each concentration, 
it suggested greater efficacy of antifungal activity 
was the concentration at 25%. these facts raise 
the possibility that the antifungal action, found in 
this study, is related to the higher concentration of 
alcohol added to propolis.
therefore, studies must be intensified, since re-
search proves natural variations in the chemical 
composition of propolis extract. in such research, 
propolis showed excellent antifungal activity, and 
the concentration was able to inhibit all the yeasts 
in 5x10-2mg/ml of flavonoids and 2x10-2mg/ml of 
flavonoids, stimulating cell death, ie 25% and 50% 
[32].
in a recent study, the activity of propolis produced 
in tocantins, in general, showed greater antifungal 
activity for C. tropicalis, with an average of 12 mm 
of inhibition zone diameter and especially the pal-
mas-Cpi propolis (16 mm). it showed a slightly lower 
activity for C. albicans, average diameter of 11 mm, 
with the best result corresponding to propolis from 
Nova Olinda-Cpi (15mm) [33].
the in vitro effect of alcoholic propolis extract 
(ApE) produced in different regions, on five species 
of micro-organisms (Staphylococcus aureus, Esche-
richia coli, Enterococcus sp., Pseudomonas aerugi-
nosa and Candida albicans) was evaluated. the re-
searchers observed that was a statistical difference 
in the Minimum inhibitory Concentration (MiC) bet-
ween the three extracts and that the Gram-positive 
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microorganisms and yeasts were those with greater 
sensitivity [34]. However, other scholars argue that 
the antimicrobial activity of propolis should be at-
tributed to all its components, as identified that the 
ApE action obtained from different locations was 
similar [35].
in this sense, the methods employed in the stu-
dies that evaluated the antimicrobial activity of pro-
polis extract were very different, making it difficult 
to compare results. However, it is recognized that 
gram-positive bacteria are more susceptible to the 
action of various propolis extracts than the Gram-
negative bacteria [36]. 
Despite the antibacterial action of propolis being 
well established in the literature, little is said of its 
antimicrobial action on yeasts. thus, it was found 
that glycolic extract of propolis was effective on C. 
albicans, even in more diluted concentrations [37]. 
Researchers evaluated the in vitro effect of alcoholic 
propolis extract on 80 species of Candida yeasts 
and found that all strains were sensitive to this ex-
tract [38]. Comparing these two studies, it should 
be emphasized that in the first [37] it was used 
glycolic propolis extract, and not the alcoholic, used 
in most studies.
Using ethanol propolis extracts, the growth of 
C. albicans and S. aureus was not inhibited, de-
monstrating that the bioactive compounds of the 
samples did not have antibiotic activity [39]. By the 
results probably the propolis acted more as a phy-
sical barrier, than as an own biological protection 
for the micro-organisms tested [40]. 
Recently, researchers [41] obtained excellent re-
sults for C. albicans, especially for acetanolic frac-
tion, wherein the minimum inhibitory concentration 
(MiC) is compared to the values found for the analy-
zed Gram-positive bacteria; contrary to the results 
found by other researchers [42], in which propolis 
extracts did not inhibit the growth of pathogens 
tested. the larger inhibition zone was of 4 mm at 
20% and 30% concentrations, being not sufficient 
to reveal antibacterial activity.
Also in this sense, few studies have proposed the 
combination of propolis extract with antimicrobial 
agents, to decrease the clinical dose of certain an-
tibiotics, as well as reducing the incidence of side 
effects and at the same time, enhance the antibio-
tical therapy [43-44]. 
Facing the exposed, the researches, overall, reveal 
more the antibacterial action of propolis than the 
antifungal.
Conclusion
Regarding the antifungal activity of red propolis, 
it was observed that its inhibitory process against 
Candida may have been influenced by the concen-
tration of alcohol present in the extract, as there 
was evidence that the lowest concentration of pro-
polis extract had higher antifungal record, compa-
red to the higher concentration. 
to test this hypothesis, it is suggested that re-
search is performed with extracts of propolis and at 
the same time with alcohol, in both different con-
centrations and environmental conditions. So, this 
study offers subsidies for other professionals assess 
this fact, performing works with extracts prepared 
with different substances and concentrations, in or-
der to test the antimicrobial action of these.
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